Hemagen Diagnostics, Inc. HMGN
0.00 USD 0.00 (+0.00%)
At close·Nov 2, 2026, 4:00 PM EST
0.0001 52-week range 0.1251
- YTD
- 0.00%
- 1 year
- +100.00%
Altman Z-Score
-14.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.5×
P/S 0.1×
P/B -0.1×
P/FCF -1.0×
EV/EBITDA -19.8×
EV/Sales 1.3×
FCF Yield -96.7%
Gross Margin 39.9%
Operating Margin -10.8%
Net Margin -22.4%
ROE 25.5%
ROIC -29.8%
ROA -37.1%
Revenue -21.4%
Operating Income 7.4%
EPS (diluted) 2.5%
Free Cash Flow -14.3%
Current Ratio 1.1×
Quick Ratio 0.4×
Debt / Equity -1.4×
Net Debt / EBITDA -18.1×
Interest Coverage -0.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2012-09-30